UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 93

Sortiert nach

Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions

British journal of cancer, 2024-05, Vol.130 (9), p.1529-1541

2024

Volltextzugriff (PDF)

Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantation

Bone marrow transplantation (Basingstoke), 2020-02, Vol.55 (2), p.419-430

2020

Volltextzugriff (PDF)

RUNX1 amplification in AML with myelodysplasia‐related changes and ring 21 chromosomes

Hematological oncology, 2017-12, Vol.35 (4), p.894-899

2017

Volltextzugriff (PDF)

NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression

International journal of laboratory hematology, 2016-02, Vol.38 (1), p.64-71

2016

Volltextzugriff (PDF)

Strong periodic acid-schiff reaction in hypervacuolated blastic plasmacytoid dendritic cell neoplasm

Diagnostic cytopathology, 2016-01, Vol.44 (1), p.39-40

2016

Volltextzugriff (PDF)

Monocytosis as prognostic factor for chronic graft versus host disease

Bone marrow transplantation (Basingstoke), 2024-06

2024

Volltextzugriff (PDF)

GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCT

Bone marrow transplantation (Basingstoke), 2015-01, Vol.50 (1), p.121-126

2015

Volltextzugriff (PDF)

Evaluation of prognostic factors among patients with chronic graft-versus-host disease

Haematologica (Roma), 2012-08, Vol.97 (8), p.1187-1195

2012

Volltextzugriff (PDF)

Effect of vitamin D treatment in chronic GVHD

Bone marrow transplantation (Basingstoke), 2011-10, Vol.46 (10), p.1395-1397

2011

Volltextzugriff (PDF)

Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: Effect of 5-AZA treatment

Leukemia research, 2012-07, Vol.36 (7), p.895-899

2012

Volltextzugriff (PDF)

Caspase-8 inhibition represses initial human monocyte activation in septic shock model

Oncotarget, 2016-06, Vol.7 (25), p.37456-37470

2016

Volltextzugriff (PDF)

The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation

Haematologica (Roma), 2012-09, Vol.97 (9), p.1329-1337

2012

Volltextzugriff (PDF)

Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population

Haematologica (Roma), 2009-07, Vol.94 (7), p.975-983

2009

Volltextzugriff (PDF)

Extreme Granulocytic Dysplasia in a De Novo Myelodysplastic Syndrome

Leukemia research, 2017-04, Vol.55, p.S78-S79

2017

Volltextzugriff (PDF)

Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting

Medical oncology (Northwood, London, England), 2018-06, Vol.35 (6), p.79-8, Article 79

2018

Volltextzugriff (PDF)

Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment

Transplantation and cellular therapy, 2022-05, Vol.28 (5), p.258.e1-258.e8

2022

Volltextzugriff (PDF)

Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Chronic Graft-versus-Host Disease

Biology of blood and marrow transplantation, 2009-10, Vol.15 (10), p.1331-1336

2009

Volltextzugriff (PDF)

Differential cytogenetic profile in advanced chronic myeloid leukemia with sequential lymphoblastic and myeloblastic blast crisis

Leukemia research reports, 2013, Vol.2 (2), p.79-81

2013

Volltextzugriff (PDF)

Prognostic factors among patients with chronic graft-versus-host disease: prognostic value of NIH classification plus type of cGVHD onset

BONE MARROW TRANSPLANTATION, 2010, Vol.45, p.S47

2010

Volltextzugriff (PDF)

127 - Extreme Granulocytic Dysplasia in a De Novo Myelodysplastic Syndrome

Leukemia research, 2017-04, Vol.55, p.S78-S79

2017

Volltextzugriff (PDF)

PS1080 LYMPHOMA ASSOCIATED HEMOPHAGOCYTIC SYNDROME: A SINGLE‐CENTER EXPERIENCE

HemaSphere, 2019-06, Vol.3 (S1), p.489-490

2019

Volltextzugriff (PDF)

NUP 98– HOXA 9 bearing therapy‐related myeloid neoplasm involves myeloid‐committed cell and induces HOXA 5 , EVI 1, FLT 3, and MEIS 1 expression

International journal of laboratory hematology, 2016-02, Vol.38 (1), p.64-71

2016

Volltextzugriff (PDF)

Classification of chronic graft-versus-host disease

Methods and findings in experimental and clinical pharmacology, 2010-12, Vol.32 Suppl A, p.65-68

2010

Volltextzugriff (PDF)

PS984 CANNABINOIDS EXERT A POTENT ANTI‐LEUKEMIC EFFECT AFFECTING SIGNALING PATHWAYS INVOLVED IN TUMOR CELL METABOLISM

HemaSphere, 2019-06, Vol.3 (S1), p.442-443

2019

Volltextzugriff (PDF)

RUNX1 amplification in AML with myelodysplasia-related changes and ring 21 chromosomes

Hematological oncology, 2017, Vol.35 (4), p.894-899

2017

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(93)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(58)
Science & Technology
(58)
Hematology
(40)
Humans
(38)
Male
(23)
Oncology
(23)
Female
(21)
Immunology
(19)
Middle Aged
(18)
Transplantation
(17)
Adult
(14)
Acute Myeloid Leukemia
(12)
Aged
(12)
Transplantation, Homologous
(12)
Leukemia
(11)
Animals
(10)
Bone Marrow
(10)
Mice
(10)
Adolescent
(9)
Hematology, Oncology And Palliative Medicine
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(21)
Biology Of Blood And Marrow Transplantation
(7)
Bone Marrow Transplantation
(6)
British Journal Of Haematology
(6)
Frontiers In Immunology
(4)
Leukemia Research
(4)
Cancers
(3)
Haematologica
(3)
Hemasphere
(3)
Annals Of Hematology
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions

Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantation

RUNX1 amplification in AML with myelodysplasia‐related changes and ring 21 chromosomes

NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression

Strong periodic acid-schiff reaction in hypervacuolated blastic plasmacytoid dendritic cell neoplasm

Monocytosis as prognostic factor for chronic graft versus host disease

GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCT

Evaluation of prognostic factors among patients with chronic graft-versus-host disease

Effect of vitamin D treatment in chronic GVHD

Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: Effect of 5-AZA treatment

Caspase-8 inhibition represses initial human monocyte activation in septic shock model

The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation

Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population

Extreme Granulocytic Dysplasia in a De Novo Myelodysplastic Syndrome

Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting

Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment

Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Chronic Graft-versus-Host Disease

Differential cytogenetic profile in advanced chronic myeloid leukemia with sequential lymphoblastic and myeloblastic blast crisis

Prognostic factors among patients with chronic graft-versus-host disease: prognostic value of NIH classification plus type of cGVHD onset

127 - Extreme Granulocytic Dysplasia in a De Novo Myelodysplastic Syndrome

PS1080 LYMPHOMA ASSOCIATED HEMOPHAGOCYTIC SYNDROME: A SINGLE‐CENTER EXPERIENCE

NUP 98– HOXA 9 bearing therapy‐related myeloid neoplasm involves myeloid‐committed cell and induces HOXA 5 , EVI 1, FLT 3, and MEIS 1 expression

Classification of chronic graft-versus-host disease

PS984 CANNABINOIDS EXERT A POTENT ANTI‐LEUKEMIC EFFECT AFFECTING SIGNALING PATHWAYS INVOLVED IN TUMOR CELL METABOLISM

RUNX1 amplification in AML with myelodysplasia-related changes and ring 21 chromosomes

Suchergebnisse filtern